Shalini Sharp, CFO & Senior Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 3,854 shares at $131.56 ($509K) on 2015-07-20, disclosed to the SEC on 2015-07-22.
Scheduled sale ($509k) by CFO & Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.99 | 488 | $64K | 12.6% |
| 2 | $131.56 | 1,412 | $186K | 36.5% |
| 3 | $132.47 | 1,954 | $259K | 50.9% |
| Total | $131.95 avg | 3,854 | $509K | 100% |
| Filing → |
| RARE | SELL | 2020-08-19 | $2.5M | — | Filing → |
| RARE | SELL | 2020-06-05 | $1.9M | — | Filing → |
| RARE | SELL | 2020-05-20 | $4.3M | — | Filing → |